Legend Biotech Corporation (LEGN)
NASDAQ·Healthcare·Biotechnology
$23.66
+0.04%
Mkt Cap $1.77B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | $307.76M | $306.30M | -0.47% | -$0.17 | -$0.08 | +52.94% | — | — |
| Q4 2025 Nov 12, 2025 | $309.53M | $272.33M | -12.02% | -$0.13 | -$0.11 | +15.38% | — | — |
| Q3 2025 Aug 11, 2025 | $278.19M | $255.95M | -7.99% | -$0.22 | -$0.34 | -54.55% | — | — |
| Q2 2025 May 13, 2025 | $218.02M | $195.05M | -10.54% | -$0.40 | -$0.07 | +82.50% | — | — |
| Q1 2025 Mar 11, 2025 | $191.31M | $186.52M | -2.50% | -$0.39 | -$0.15 | +61.54% | — | — |
| Q3 2024 Aug 9, 2024 | $134.69M | $186.52M | +38.48% | -$0.54 | -$0.05 | +90.74% | — | — |
| Q2 2024 May 13, 2024 | $126.59M | $93.99M | -25.75% | -$0.29 | -$0.16 | +44.83% | — | — |
| Q1 2024 Mar 11, 2024 | $86.52M | $79.46M | -8.16% | -$0.70 | -$0.40 | +42.86% | — | — |
| Q4 2023 Nov 20, 2023 | $97.25M | $96.01M | -1.28% | -$0.56 | -$0.17 | +69.64% | — | — |
| Q3 2023 Aug 15, 2023 | $54.62M | $73.33M | +34.25% | -$0.69 | -$0.27 | +60.87% | — | — |
| Q2 2023 May 18, 2023 | $54.68M | $36.34M | -33.55% | -$0.56 | -$0.40 | +28.57% | — | — |
| Q1 2023 Mar 30, 2023 | $36.06M | $27.63M | -23.37% | -$0.44 | -$0.85 | -94.17% | — | — |
| Q3 2022 Sep 30, 2022 | — | $27.36M | — | — | -$0.54 | — | — | — |
| Q2 2022 Jun 1, 2022 | $25.00M | $11.97M | -52.12% | -$0.37 | -$0.24 | +35.14% | — | — |
| Q1 2022 Mar 18, 2022 | $14.27M | $40.83M | +186.09% | -$0.35 | -$0.38 | -8.57% | — | — |
| Q4 2021 Dec 31, 2021 | — | $38.99M | — | — | -$0.60 | — | — | — |
| Q4 2021 Nov 16, 2021 | $7.83M | $16.88M | +115.51% | -$0.35 | -$0.43 | -22.86% | — | — |
| Q3 2021 Aug 23, 2021 | $7.83M | $20.23M | +158.40% | -$0.31 | -$0.32 | -3.23% | — | — |
| Q2 2021 May 18, 2021 | $15.64M | $13.68M | -12.50% | -$0.35 | -$0.30 | +14.29% | — | — |
| Q1 2021 Mar 18, 2021 | — | $40.78M | — | -$0.28 | -$0.22 | +21.43% | — | — |